BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 12373309)

  • 1. Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B.
    Hanada S; Kumashiro R; Kaji R; Harada M; Sata M
    Int J Mol Med; 2002 Nov; 10(5):647-8. PubMed ID: 12373309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine.
    Sponseller CA; Bacon BR; Di Bisceglie AM
    Liver Transpl; 2000 Nov; 6(6):715-20. PubMed ID: 11084057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and safety of long-term lamivudine therapy in the patients with decompensated liver cirrhosis secondary to hepatitis B].
    Park TW; Park YM; Bae SH; Jang JW; Nam SW; Choi JY; Yoon SK; Cho SH; Yang JM; Han NI; Ahn BM; Lee YS; Lee CD; Park DH
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):428-35. PubMed ID: 12506247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective and comparative cohort study on efficacy and drug resistance during long-term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis.
    Nishida T; Kobashi H; Fujioka S; Fujio K; Takaguchi K; Ikeda H; Kawaguchi M; Ando M; Araki Y; Higashi T; Shoji B; Takaki A; Iwasaki Y; Sakaguchi K; Shiratori Y; Yamamoto K
    J Gastroenterol Hepatol; 2008 May; 23(5):794-803. PubMed ID: 18086120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamivudine treatment of decompensated hepatitis B virus-related cirrhosis.
    Zhang FK
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):10-5. PubMed ID: 16481275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamivudine treatment of advanced and decompensated liver disease due to hepatitis B.
    Van Thiel DH; Friedlander L; Kania RJ; Molloy PJ; Hassanein T; Wahlstrom E; Faruki H
    Hepatogastroenterology; 1997; 44(15):808-12. PubMed ID: 9222695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of lamivudine therapy for decompensated liver cirrhosis due to hepatitis B virus with or without hepatocellular carcinoma.
    Hiraoka A; Michitaka K; Kumagi T; Kurose K; Uehara T; Hirooka M; Yamashita Y; Kubo Y; Miyaoka H; Iuchi H; Okada S; Ohmoto M; Yamamoto K; Horiike N; Onji M
    Oncol Rep; 2005 Jun; 13(6):1159-63. PubMed ID: 15870937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus-related cirrhosis: natural history and treatment.
    Chu CM; Liaw YF
    Semin Liver Dis; 2006 May; 26(2):142-52. PubMed ID: 16673292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamivudine treatment in patients with hepatitis B virus induced liver cirrhosis.
    Cetin K; Sabahattin K; Kadir D; Ahmet D; Ziyaettin D; Selim B; Mürüvvet B; Fatih B; Güngör B; Zeynel M; Yilmaz C; Atilla O
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxcv-ccxcvii. PubMed ID: 15244206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic efficacy of lamivudine in patients with hepatitis B virus-related decompensated cirrhosis in Korea].
    Jung S; Suh DJ; Park HJ; Park YH; Song HG; Lee HC; Chung YH; Lee YS
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):418-27. PubMed ID: 12506246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
    Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on efficacy of lamivudine therapy in decompensated cirrhosis of liver due to chronic hepatitis B virus infection.
    Sharma YR; Miah AR; Saha SK; Mohammed S; Rahman M; Roy PK; Hasan M
    Nepal Med Coll J; 2004 Dec; 6(2):106-11. PubMed ID: 16295739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of patients with decompensated HBV cirrhosis.
    Fontana RJ
    Semin Liver Dis; 2003 Feb; 23(1):89-100. PubMed ID: 12616454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis.
    Viganò M; Colombo M; Aroldi A; Lunghi G; Manenti E; Ponticelli C; Lampertico P
    Antivir Ther; 2005; 10(6):709-13. PubMed ID: 16218169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation.
    Woo HY; Choi JY; Jang JW; You CR; Bae SH; Yoon SK; Yang JM; Choi SW; Han NI; Kim DG
    J Med Virol; 2008 Nov; 80(11):1891-9. PubMed ID: 18814257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [One year and half treatment with lamivudine in active cirrhosis resulting from chronic hepatitis B].
    Zeng WQ; Guo SH; Zhang DZ; Zhou Z; Ren H; Zhang QH; Wang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):176-8. PubMed ID: 12681069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis.
    Hann HW; Fontana RJ; Wright T; Everson G; Baker A; Schiff ER; Riely C; Anschuetz G; Gardner SD; Brown N; Griffiths D;
    Liver Transpl; 2003 Jan; 9(1):49-56. PubMed ID: 12514773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
    Ferretti G; Merli M; Ginanni Corradini S; Callejon V; Tanzilli P; Masini A; Ferretti S; Iappelli M; Rossi M; Rivanera D; Lilli D; Mancini C; Attili A; Berloco P
    Transplant Proc; 2004 Apr; 36(3):535-8. PubMed ID: 15110584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term effects of lamivudine treatment in patients with HBeAg-negative liver cirrhosis.
    Kilic ZM; Kuran S; Akdogan M; Cicek B; Oguz D; Odemis B; Sasmaz N
    Adv Ther; 2008 Mar; 25(3):190-200. PubMed ID: 18385953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lamivudine treatment in patients with decompensated cirrhosis due to anti-HBe positive/HBeAg-negative chronic hepatitis B.
    Nikolaidis N; Vassiliadis T; Giouleme O; Tziomalos K; Grammatikos N; Patsiaoura K; Orfanou-Koumerkeridou E; Balaska A; Eugenidis N
    Clin Transplant; 2005 Jun; 19(3):321-6. PubMed ID: 15877792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.